All News Xeris Biopharma Holdings, Inc.

Equities

XERS

US98422E1038

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-10 pm EDT			5-day change	1st Jan Change
1.76 ^USD	-6.38%		-6.88%	-25.11%

May. 09	Transcript : Xeris Biopharma Holdings, Inc., Q1 2024 Earnings Call, May 09, 2024
May. 09	Earnings Flash (XERS) XERIS BIOPHARMA HOLDINGS Reports Q1 Revenue $40.6M, vs. Street Est of $41.8M	MT

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Xeris Biopharma Holdings, Inc., Q1 2024 Earnings Call, May 09, 2024	May. 09
Earnings Flash (XERS) XERIS BIOPHARMA HOLDINGS Reports Q1 Revenue $40.6M, vs. Street Est of $41.8M	May. 09	MT
Xeris Biopharma: Q1 Earnings Snapshot	May. 09	AQ
Xeris Biopharma Reports First Quarter 2024 Financial Results and Recent Events	May. 09	BU
Xeris Biopharma Holdings, Inc. Provides Revenue Guidance for the Full Year 2024	May. 09	CI
Xeris Biopharma Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 09	CI
Xeris Biopharma Collaborating With Beta Bionics for Development, Commercialization of Glucagon Product	May. 06	MT
Xeris Enters Into an Exclusive Worldwide Collaboration and License Agreement with Beta Bionics	May. 06	BU
Xeris Biopharma to Report First Quarter 2024 Financial Results on May 9, 2024	May. 02	BU
Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	Apr. 03	BU
Xeris Biopharma to Participate in the 23rd Annual Needham Virtual Healthcare Conference	Apr. 02	BU
Oppenheimer Initiates Coverage on Xeris Biopharma With Outperform Rating, $5 Price Target	Mar. 28	MT
Xeris Biopharma Holdings, Inc.(NasdaqGS:XERS) added to S&P Pharmaceuticals Select Industry Index	Mar. 17	CI
Transcript : Xeris Biopharma Holdings, Inc., Q4 2023 Earnings Call, Mar 06, 2024	Mar. 06
Xeris Biopharma: Q4 Earnings Snapshot	Mar. 06	AQ
Earnings Flash (XERS) XERIS BIOPHARMA HOLDINGS Reports Q4 Revenue $44.4M, vs. Street Est of $43.6M	Mar. 06	MT
Xeris Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Events	Mar. 06	BU
Xeris Refinances Its $150M Senior Secured Term Loan Facility With Hayfin Capital	Mar. 06	BU
Xeris Biopharma Holdings, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Mar. 06	CI
Xeris Biopharma Holdings, Inc. Provides Earnings Guidance for the Year 2024	Mar. 06	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Xeris Biopharma Holdings, Inc.

Equities

XERS

US98422E1038

All News

Filters